Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.58 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azosemide SCHEMBL30754398 | 0.82 | PDE4D (0.70) | PDE4DPDE3ACISD1APPPOLB | |
| Azosemide SCHEMBL48976 | 0.82 | PDE4D (0.70) | PDE4DPDE3ACISD1APPPOLB | |
| Azosemide SCHEMBL4421865 | 0.82 | PDE4D (0.70) | PDE4DPDE3ACISD1APPPOLB | |
| Azosemide SCHEMBL8988688 | 0.82 | PDE4D (0.69) | PDE4DPDE3ACISD1APPPOLB | |
| SCHEMBL18993721 | 0.77 | PDE4D (0.62) | PDE4DPDE3ACISD1POLBCA12 | |
| Azosemide SCHEMBL230626 | 0.77 | PDE4D (0.62) | PDE4DPDE3ACISD1APPPOLB | |
| SCHEMBL231240 | 0.76 | PDE4D (0.61) | PDE4DPDE3ACISD1POLBCA12 | |
| SCHEMBL18993718 | 0.74 | PDE4D (0.59) | PDE4DPDE3ACISD1POLBCA12 | |
| Azosemide SCHEMBL231405 | 0.74 | PDE4D (0.58) | PDE4DPDE3ACISD1APPPOLB | |
| SCHEMBL1714459 | 0.74 | CISD1 (1.00) | PDE4DPDE3ACISD1APPPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118754869-A | Preparation method and application of high-purity methane disulfonic acid methylene ester capable of reducing three wastes | 联泓(江苏)新材料研究院有限公司 | 2024-10-11 | — | — | CN | claimed |
| US-20230382838-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | AESICA PHARMACEUTICALS LIMITED (GB) | 2023-11-30 | — | — | US | claimed |
| CN-116143373-A | Chicken manure steam explosion pretreatment machine | 巴州友质种业有限公司 | 2023-05-23 | — | — | CN | claimed |
| US-12625441-B2 | Electrostatic charge image developing toner and image forming method | Konica Minolta, Inc. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-3431488-B1 | METHOD FOR PRODUCING CRYSTAL OF REDUCED GLUTATHIONE | KYOWA HAKKO BIO CO LTD (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12619152-B2 | Method for producing actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method, method for producing electronic device, and method for producing onium salt | FUJIFILM CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12601992-B2 | Developing roller, process cartridge, electrophotographic image forming apparatus, and electrophotographic image forming system | Konica Minolta, Inc. (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-2838129-B1 | COMPOSITION FOR ORGANIC ELECTROLUMINESCENT ELEMENTS | MITSUBISHI CHEM CORP (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260049264-A1 | CHEMICAL SOLUTION AND CHEMICAL SOLUTION-HOUSING ARTICLE | FUJIFILM CORP (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260042089-A1 | METHOD FOR PRODUCING CATION EXCHANGE RESIN AND METHOD FOR REFINING ORGANIC ACID SOLUTION | ORGANO CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4656713-A1 | CELL AGGREGATE DISSOCIATING AGENT | AJINOMOTO CO., INC. (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20060134198-A1 | Pharmaceutical compositions with improved dissolution | JOHNSON & JOHNSON CONSUMER INC. | 2006-06-22 | — | — | US | disclosed |
| US-20060052432-A1 | Pharmaceutical compositions with improved dissolution | TRANSFORM PHARMACEUTICALS, INC. | 2006-03-09 | — | — | US | disclosed |
| EP-1579198-A1 | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION | Transform Pharmaceuticals, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| CN-1668283-A | Pharmaceutical composition with improved dissolution | TRANSFORM PHARMACEUTICALS INC (US) | 2005-09-14 | — | — | CN | disclosed |
| EP-1515703-A1 | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION | Transform Pharmaceuticals, Inc. (US) | 2005-03-23 | — | — | EP | disclosed |
| US-20050025791-A1 | Pharmaceutical compositions with improved dissolution | TRANSFORM PHARMACEUTICALS, INC. | 2005-02-03 | — | — | US | disclosed |
| WO-2004061433-A1 | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION | TRANSFORM PHARMACEUTICALS, INC. (US) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004026235-A2 | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION | TRANSFORM PHARMACEUTICALS, INC. (US) | 2004-04-01 | — | — | WO | disclosed |
| WO-2004000284-A1 | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED DISSOLUTION | TRANSFORM PHARMACEUTICALS, INC. (US) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049264-A1 | CHEMICAL SOLUTION AND CHEMICAL SOLUTION-HOUSING ARTICLE | OR10J3, PPM1D, PPM1F | PDE4D 3170/4885PDE3A 3025/4885CISD1 2128/4885 |
| US-20050025791-A1 | Pharmaceutical compositions with improved dissolution | ABCG2, SI, SLC10A2 | PDE4D 1755/4885PDE3A 744/4885CISD1 3478/4885 |
| US-12619152-B2 | Method for producing actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method, method for producing electronic device, and method for producing onium salt | ROCK2, ROCK1, SLC9A5 | PDE4D 1568/4885PDE3A 1751/4885CISD1 3145/4885 |
| US-20230382838-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | CNR2, CNR1, C1R | PDE4D 4782/4885PDE3A 4781/4885CISD1 866/4885 |
| US-20060052432-A1 | Pharmaceutical compositions with improved dissolution | ABCG2, SI, SLC10A2 | PDE4D 1868/4885PDE3A 616/4885CISD1 3219/4885 |
| US-20260042089-A1 | METHOD FOR PRODUCING CATION EXCHANGE RESIN AND METHOD FOR REFINING ORGANIC ACID SOLUTION | ME1, SLC25A11, SLC7A1 | PDE4D 4885/4885PDE3A 4830/4885CISD1 1604/4885 |
| US-20060134198-A1 | Pharmaceutical compositions with improved dissolution | ABCG2, SI, SLC10A2 | PDE4D 1868/4885PDE3A 616/4885CISD1 3219/4885 |
| US-12601992-B2 | Developing roller, process cartridge, electrophotographic image forming apparatus, and electrophotographic image forming system | MARK4, MAP1LC3B, MAP1LC3A | PDE4D 3358/4885PDE3A 4858/4885CISD1 3050/4885 |
| US-12625441-B2 | Electrostatic charge image developing toner and image forming method | EWSR1, AFF4, DYRK2 | PDE4D 2009/4885PDE3A 2610/4885CISD1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.